Epinephrine Injector
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-26-R-0009
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to procure Epinephrine 0.3 MG/0.3 ML Injection Auto-Injectors in 2-count bottles through a national requirements contract. This unrestricted and fully competitive acquisition will be conducted as a commercial item procurement under FAR Part 12, meaning all sources are eligible to submit proposals. The contract will be structured as a firm-fixed price requirements contract with a one-year base period and four one-year options, establishing a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. While specific evaluation criteria are not detailed in this pre-solicitation notice, the commercial nature of the acquisition suggests standard commercial evaluation factors will apply. Interested parties should contact Jeremy Brown at (445) 737-5419 or jeremy.brown@dla.mil with questions, and the solicitation is projected to be issued in August 2026, though the DLA reserves the right to adjust this timeline.
No set-aside designations have been applied to this procurement, making it fully open to competition. The pre-solicitation notice does not identify any incumbent contractors or provide specific award values or budget ranges. Annual usage estimates will be made available in the Schedule of Supplies section when the formal solicitation is released. Interested parties are advised to monitor the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov for the solicitation release and to establish automated notifications for any updates to the pre-solicitation or subsequent solicitation. The commercial item classification under NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals) indicates this procurement falls within the pharmaceutical and biologicals supply category.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Epinephrine Injectors. Procurement details follow.
Epinephrine 0.3 MG/0.3 ML Injection, Auto-Injector 2S in 2 count bottles.
This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov. Interested parties should contact Jeremy Brown at (445) 737-5419, (jeremy.brown@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is August of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Epinephrine Injector | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity